CARDIO PART III

Determinants of Myocardial Oxygen Supply and Demand

Oxygen DEMAND ↑ by

Oxygen SUPPLY depends on

❤ Heart rate

🩸 Coronary blood flow (patency + perfusion pressure)

💪 Contractility

⏱ Diastolic filling time

🧱 Wall stress (preload + afterload)

🫁 O₂ content (Hgb, saturation)

Why is coronary perfusion mostly diastolic?

  • During systole, the contracting ventricle compresses its own intramyocardial vessels → flow is squeezed down.

  • During diastole, the myocardium relaxes → vessels open → LV coronary perfusion peaks.

  • 🔴 Clinical pearl: Tachycardia shortens diastole → less perfusion time and higher demand = double hit.

  • This is why rate control matters.


Why does ischemia occur?

  • When supply can't meet demand → aerobic ATP production fails → contractility drops + electrical instability.

  • If flow returns early → recovery

  • if prolonged → necrosis.

Collateral circulation

  • Gradual, chronic narrowing → time to grow collateral vessels (alternate routes).

  • 🧠 "Slow block builds bridges."

  • Limitations

    • varies person-to-person, takes time, and cannot compensate for sudden complete occlusion (that's why ACS/MI happens abruptly).


Pathophysiology and Classification of Angina Pectoris

  • Definition and Core Distinction:

    • Angina Pectoris: Chest discomfort resulting from transient myocardial ischemia

    • characterized by cellular hypoxia without myocardial cell death

Type

Mechanism

Pattern/Trigger

Stable

Fixed atherosclerotic narrowing; demand > supply

Predictable with exertion; relieved by rest

Variant (Prinzmetal)

Coronary vasospasm

Often at rest (overnight/early AM); responds to vasodilators

Unstable

Acute plaque disruption + reduced flow

New, worsening, or rest symptoms → ACS — urgent!

🧠 "Stable = stairs. Variant = vasospasm at rest. Unstable = unpredictable → emergency."

Why ischemia is reversible but infarction is not:

  • ischemia = impaired ATP/function (cells still alive)

  • infarction = irreversible cell death with release of intracellular contents (troponin).

1.4 Symptom relief ≠ prevention (THE distinction)

  • Symptom-relieving antianginals improve the supply–demand balance → relieve ischemia today.

  • They do NOT remove plaque, stop thrombosis, or lower future MI risk.

  • 🛡 Risk-reducing therapy

    • statins, antiplatelets

    • ACEi/ARBs

    • lifestyle → targets atherosclerosis + thrombosis → lowers future MI.

  • 🧠 "Relievers treat the moment; preventers treat the future."


Acute Coronary Syndrome (ACS) Spectrum and Diagnostics

  • Pathophysiological Cascade:

Plaque rupture/erosion → exposes subendothelial collagen + tissue factor → platelet adhesion/activation/aggregation → coagulation cascade → thrombus → ↓ coronary flow → ischemia → possible necrosis.


  • Why ACS is an acute thrombotic event, not just gradual plaque growth:

    • Stable angina = fixed, gradual narrowing (demand mismatch).

    • ACS = sudden plaque disruption + thrombus → abrupt flow reduction → acute ischemia at rest.

  • 🧠 "Stable = slow clog. ACS = sudden clot."


  • The Three Classifications of Acute Coronary Syndrome:

    Feature

    Unstable Angina

    NSTEMI

    STEMI

    Coronary problem

    Acute ↓ flow

    Acute ischemia → infarct

    Complete occlusion / severe ↓ flow

    Myocardial necrosis?

    ❌ No

    ✅ Yes (subendocardial)

    ✅ Yes (transmural)

    Troponin

    No acute rise

    Elevated

    Elevated

    ECG

    Normal or no ST elevation

    Normal, ST depression, T inversion (no ST elevation)

    Persistent ST elevation (or STEMI-equivalent)

    Urgency

    Urgent eval

    MI care

    Reperfusion EMERGENCY

    🧠 ECG trick: "S-T-E-M-I = ST Elevation = Muscle Infarct (full thickness)."


  • Why troponin indicates injury, but ECG — not troponin height — distinguishes STEMI vs. NSTEMI:

    • Troponin = marker of myocardial injury (any cause — not the pattern of injury).

    • ECG shows the territory/transmural extent of ischemia → drives the STEMI vs. NSTEMI decision.

  • 🧠 "Troponin says if; ECG says where/how bad."


  • Why unstable angina needs urgent evaluation despite no necrosis:

    • it's an ACS — plaque is disrupted, thrombus is forming

    • can progress to MI

    • No troponin rise ≠ safe


  • Why the "partial vs. complete occlusion" rule isn't absolute

    • a "partial" lesion can behave like a complete one (and vice versa)

    • Treat the patient + ECG + biomarkers, not a rule of thumb

Broad ACS treatment goals

  1. Relieve ischemia (anti-ischemic therapy)

  2. Limit thrombus propagation (antiplatelets + anticoagulants)

  3. Reduce further injury (statins, oxygen only if hypoxemic, beta blockers when stable)

  4. Consider revascularization (PCI; fibrinolysis only for eligible STEMI)


Purpose of each:

  • Antiplatelets → block platelet aggregation (prevent thrombus growth)

  • Anticoagulants → limit clot propagation

  • Statins → stabilize plaque, lower long-term atherosclerotic risk

  • Anti-ischemic → ↓ demand / improve supply

  • PCI → mechanically restore flow


Why fibrinolytics are NOT indicated for UA/NSTEMI

  • these are usually partial occlusions

  • Lysis adds bleeding risk without proven benefit

  • best managed with antiplatelets/anticoagulants + PCI if needed

  • 🧠 "Lytics are for complete block (STEMI) only."


Management of Acute Myocardial Infarction and Reperfusion

  • Manifestations — typical & atypical

    • Typical: persistent chest pressure/tightness/heaviness at rest, radiating to arm/shoulder/jaw/neck/back; dyspnea, diaphoresis, nausea, dizziness.

    • Atypical: minimal/no chest pain — especially older adults,

    • diabetes; women more often report nausea, dyspnea, fatigue.

  • ⚠ Absence of crushing chest pain does NOT exclude MI. 🧠 "No classic pain ≠ no MI."


  • Troponin — how to think about it (don't memorize a single cutoff)

    • Troponin = protein in cardiac muscle; leaks when cells are injured.

    • Elevated troponin alone ≠ acute MI

  • 🧠 "Trend + story + ECG = diagnosis."


  • Consequences of infarction (location + size matter)

    • Necrotic tissue can't contract

      • ↓ contractility → ↓ stroke volume → ↓ cardiac output.

    • ↓ Ejection fraction with significant LV damage.

    • Electrical instability

      • dysrhythmias

    • Ventricular remodeling

      • progressive dysfunction.

  • Extensive damage → heart failure or cardiogenic shock.

  • 🧠 "Bigger infarct = bigger pump failure."


  • Reperfusion Strategies for STEMI:

    • PCI = catheter-based; balloon + stent

      • mechanically restores flow

      • preferred for STEMI when promptly available (goal ~90 min first medical contact; ~120 min if transfer).

    • Fibrinolytics = dissolve fibrin in thrombus

      • option only when timely PCI unavailable and patient eligible; best early; bleeding risk (contraindications matter); target ~30 min of arrival.

    • 🧠 "PCI = plumbing. Lytics = draino. PCI first if you can get it fast."


STEMI treatment categories (why one drug can't do it all)

Pathophysiologic problem

Treatment strategy

Coronary obstruction

PCI (or fibrinolysis if selected)

Platelet activation/aggregation

Antiplatelets

Ongoing thrombus

Anticoagulants

↑ O₂ demand

Nitrates / selected beta blockers

Underlying atherosclerosis

High-intensity statin + risk factors

Hypoxemia

Oxygen only if hypoxemic (not routine)

🧠 "No single med fixes obstruction + clot + demand + cholesterol — treat all four."